217 related articles for article (PubMed ID: 17940638)
1. Alvimopan: a peripherally acting mu-opioid receptor antagonist.
Leslie JB
Drugs Today (Barc); 2007 Sep; 43(9):611-25. PubMed ID: 17940638
[TBL] [Abstract][Full Text] [Related]
2. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection.
Wolff BG; Weese JL; Ludwig KA; Delaney CP; Stamos MJ; Michelassi F; Du W; Techner L
J Am Coll Surg; 2007 Apr; 204(4):609-16. PubMed ID: 17382220
[TBL] [Abstract][Full Text] [Related]
3. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies.
Delaney CP; Wolff BG; Viscusi ER; Senagore AJ; Fort JG; Du W; Techner L; Wallin B
Ann Surg; 2007 Mar; 245(3):355-63. PubMed ID: 17435541
[TBL] [Abstract][Full Text] [Related]
4. Alvimopan.
Curran MP; Robins GW; Scott LJ; Perry CM
Drugs; 2008; 68(14):2011-9. PubMed ID: 18778122
[TBL] [Abstract][Full Text] [Related]
5. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.
Wolff BG; Michelassi F; Gerkin TM; Techner L; Gabriel K; Du W; Wallin BA;
Ann Surg; 2004 Oct; 240(4):728-34; discussion 734-5. PubMed ID: 15383800
[TBL] [Abstract][Full Text] [Related]
6. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability.
Viscusi ER; Gan TJ; Leslie JB; Foss JF; Talon MD; Du W; Owens G
Anesth Analg; 2009 Jun; 108(6):1811-22. PubMed ID: 19448206
[TBL] [Abstract][Full Text] [Related]
7. Alvimopan for the management of postoperative ileus.
Leslie JB
Ann Pharmacother; 2005 Sep; 39(9):1502-10. PubMed ID: 16076918
[TBL] [Abstract][Full Text] [Related]
8. Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use.
Senagore AJ; Bauer JJ; Du W; Techner L
Surgery; 2007 Oct; 142(4):478-86. PubMed ID: 17950339
[TBL] [Abstract][Full Text] [Related]
9. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.
Kauf TL; Svatek RS; Amiel G; Beard TL; Chang SS; Fergany A; Karnes RJ; Koch M; O'Hara J; Lee CT; Sexton WJ; Slaton JW; Steinberg GD; Wilson SS; Techner L; Martin C; Moreno J; Kamat AM
J Urol; 2014 Jun; 191(6):1721-7. PubMed ID: 24342144
[TBL] [Abstract][Full Text] [Related]
10. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologist's view and beyond.
Sinatra RS
J Perianesth Nurs; 2006 Apr; 21(2A Suppl):S16-23. PubMed ID: 16597531
[TBL] [Abstract][Full Text] [Related]
11. Alvimopan.
Neary P; Delaney CP
Expert Opin Investig Drugs; 2005 Apr; 14(4):479-88. PubMed ID: 15882122
[TBL] [Abstract][Full Text] [Related]
12. Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion.
Vora AA; Harbin A; Rayson R; Christiansen K; Ghasemian R; Hwang J; Verghese M
Can J Urol; 2012 Jun; 19(3):6293-8. PubMed ID: 22704317
[TBL] [Abstract][Full Text] [Related]
13. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
[TBL] [Abstract][Full Text] [Related]
14. Economic Impact of Alvimopan Considering Varying Definitions of Postoperative Ileus.
Earnshaw SR; Kauf TL; McDade C; Potashman MH; Pauyo C; Reese ES; Senagore A
J Am Coll Surg; 2015 Nov; 221(5):941-50. PubMed ID: 26353904
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus.
Kraft MD
Expert Opin Investig Drugs; 2008 Sep; 17(9):1365-77. PubMed ID: 18694369
[TBL] [Abstract][Full Text] [Related]
16. Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist.
Schmidt WK
Am J Surg; 2001 Nov; 182(5A Suppl):27S-38S. PubMed ID: 11755894
[TBL] [Abstract][Full Text] [Related]
17. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.
Delaney CP; Weese JL; Hyman NH; Bauer J; Techner L; Gabriel K; Du W; Schmidt WK; Wallin BA;
Dis Colon Rectum; 2005 Jun; 48(6):1114-25; discussion 1125-6; author reply 1127-9. PubMed ID: 15906123
[TBL] [Abstract][Full Text] [Related]
18. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor.
DeHaven-Hudkins DL; DeHaven RN; Little PJ; Techner LM
Pharmacol Ther; 2008 Jan; 117(1):162-87. PubMed ID: 18022696
[TBL] [Abstract][Full Text] [Related]
19. Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
Jang J; Kwok B; Zhong H; Xia Y; Grucela A; Bernstein M; Remzi F; Hudesman D; Chen J; Axelrad J; Chang S
Dig Dis Sci; 2020 Apr; 65(4):1164-1171. PubMed ID: 31522323
[TBL] [Abstract][Full Text] [Related]
20. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.
Lee CT; Chang SS; Kamat AM; Amiel G; Beard TL; Fergany A; Karnes RJ; Kurz A; Menon V; Sexton WJ; Slaton JW; Svatek RS; Wilson SS; Techner L; Bihrle R; Steinberg GD; Koch M
Eur Urol; 2014 Aug; 66(2):265-72. PubMed ID: 24630419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
